Literature DB >> 23951085

Lentiviral vector-mediated gradients of GDNF in the injured peripheral nerve: effects on nerve coil formation, Schwann cell maturation and myelination.

Ruben Eggers1, Fred de Winter, Stefan A Hoyng, Kasper C D Roet, Erich M Ehlert, Martijn J A Malessy, Joost Verhaagen, Martijn R Tannemaat.   

Abstract

Although the peripheral nerve is capable of regeneration, only a small minority of patients regain normal function after surgical reconstruction of a major peripheral nerve lesion, resulting in a severe and lasting negative impact on the quality of life. Glial cell-line derived neurotrophic factor (GDNF) has potent survival- and outgrowth-promoting effects on motoneurons, but locally elevated levels of GDNF cause trapping of regenerating axons and the formation of nerve coils. This phenomenon has been called the "candy store" effect. In this study we created gradients of GDNF in the sciatic nerve after a ventral root avulsion. This approach also allowed us to study the effect of increasing concentrations of GDNF on Schwann cell proliferation and morphology in the injured peripheral nerve. We demonstrate that lentiviral vectors can be used to create a 4 cm long GDNF gradient in the intact and lesioned rat sciatic nerve. Nerve coils were formed throughout the gradient and the number and size of the nerve coils increased with increasing GDNF levels in the nerve. In the nerve coils, Schwann cell density is increased, their morphology is disrupted and myelination of axons is severely impaired. The total number of regenerated and surviving motoneurons is not enhanced after the distal application of a GDNF gradient, but increased sprouting does result in higher number of motor axon in the distal segment of the sciatic nerve. These results show that lentiviral vector mediated overexpression of GDNF exerts multiple effects on both Schwann cells and axons and that nerve coil formation already occurs at relatively low concentrations of exogenous GDNF. Controlled expression of GDNF, by using a viral vector with regulatable GDNF expression, may be required to avoid motor axon trapping and to prevent the effects on Schwann cell proliferation and myelination.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23951085      PMCID: PMC3741360          DOI: 10.1371/journal.pone.0071076

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  37 in total

1.  Inhibition of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor expression reduces dopaminergic sprouting in the injured striatum.

Authors:  P E Batchelor; G T Liberatore; M J Porritt; G A Donnan; D W Howells
Journal:  Eur J Neurosci       Date:  2000-10       Impact factor: 3.386

Review 2.  Signals that determine Schwann cell identity.

Authors:  K R Jessen; R Mirsky
Journal:  J Anat       Date:  2002-04       Impact factor: 2.610

3.  Macrophages and Microglia Produce Local Trophic Gradients That Stimulate Axonal Sprouting Toward but Not beyond the Wound Edge.

Authors:  P E Batchelor; M J Porritt; P Martinello; C L Parish; G T Liberatore; G A Donnan; D W Howells
Journal:  Mol Cell Neurosci       Date:  2002-11       Impact factor: 4.314

4.  Nerve allografts supplemented with schwann cells overexpressing glial-cell-line-derived neurotrophic factor.

Authors:  Katherine B Santosa; Nithya J Jesuraj; Andreu Viader; Matthew MacEwan; Piyaraj Newton; Daniel A Hunter; Susan E Mackinnon; Philip J Johnson
Journal:  Muscle Nerve       Date:  2012-11-21       Impact factor: 3.217

5.  Overexpression of GDNF induces and maintains hyperinnervation of muscle fibers and multiple end-plate formation.

Authors:  M Zwick; L Teng; X Mu; J E Springer; B M Davis
Journal:  Exp Neurol       Date:  2001-10       Impact factor: 5.330

6.  Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer.

Authors:  Biljana Georgievska; Deniz Kirik; Anders Björklund
Journal:  Exp Neurol       Date:  2002-10       Impact factor: 5.330

7.  A decline in glial cell-line-derived neurotrophic factor expression is associated with impaired regeneration after long-term Schwann cell denervation.

Authors:  A Höke; T Gordon; D W Zochodne; O A R Sulaiman
Journal:  Exp Neurol       Date:  2002-01       Impact factor: 5.330

8.  Glial cell line-derived neurotrophic factor alters axon schwann cell units and promotes myelination in unmyelinated nerve fibers.

Authors:  Ahmet Höke; Tony Ho; Thomas O Crawford; Carl LeBel; Dana Hilt; John W Griffin
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

9.  Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects.

Authors:  Yi Ai; William Markesbery; Zhiming Zhang; Richard Grondin; Dennis Elseberry; Greg A Gerhardt; Don M Gash
Journal:  J Comp Neurol       Date:  2003-06-23       Impact factor: 3.215

10.  BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents.

Authors:  Lian Mai; Richard S Jope; Xiaohua Li
Journal:  J Neurochem       Date:  2002-07       Impact factor: 5.372

View more
  25 in total

1.  Role of Nectin-1/c-Src Signaling in the Analgesic Effect of GDNF on a Rat Model of Chronic Constrictive Injury.

Authors:  Yuan-Yuan Gao; Xiao-Ya Hong; Hong-Jun Wang
Journal:  J Mol Neurosci       Date:  2016-07-09       Impact factor: 3.444

2.  Gene delivery to rat and human Schwann cells and nerve segments: a comparison of AAV 1-9 and lentiviral vectors.

Authors:  S A Hoyng; F De Winter; S Gnavi; L van Egmond; C L Attwell; M R Tannemaat; J Verhaagen; M J A Malessy
Journal:  Gene Ther       Date:  2015-05-04       Impact factor: 5.250

3.  Transgenic SCs expressing GDNF-IRES-DsRed impair nerve regeneration within acellular nerve allografts.

Authors:  Xueping Ee; Ying Yan; Daniel A Hunter; Lauren Schellhardt; Shelly E Sakiyama-Elbert; Susan E Mackinnon; Matthew D Wood
Journal:  Biotechnol Bioeng       Date:  2017-05-18       Impact factor: 4.530

Review 4.  Electrical Stimulation to Enhance Axon Regeneration After Peripheral Nerve Injuries in Animal Models and Humans.

Authors:  Tessa Gordon
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

5.  Finely Tuned Temporal and Spatial Delivery of GDNF Promotes Enhanced Nerve Regeneration in a Long Nerve Defect Model.

Authors:  Laura M Marquardt; Xueping Ee; Nisha Iyer; Daniel Hunter; Susan E Mackinnon; Matthew D Wood; Shelly E Sakiyama-Elbert
Journal:  Tissue Eng Part A       Date:  2015-12       Impact factor: 3.845

6.  Neurotrophin selectivity in organizing topographic regeneration of nociceptive afferents.

Authors:  Lakshmi Kelamangalath; Xiaoqing Tang; Kathleen Bezik; Noelle Sterling; Young-Jin Son; George M Smith
Journal:  Exp Neurol       Date:  2015-06-06       Impact factor: 5.330

7.  Viral transduction of primary Schwann cells using a Cre-lox system to regulate GDNF expression.

Authors:  Yuewei Wu-Fienberg; Amy M Moore; Laura M Marquardt; Piyaraj Newton; Philip J Johnson; Susan E Mackinnon; Shelly E Sakiyama-Elbert; Matthew D Wood
Journal:  Biotechnol Bioeng       Date:  2014-04-24       Impact factor: 4.530

8.  An Epigenetic Mechanism of High Gdnf Transcription in Glioma Cells Revealed by Specific Sequence Methylation.

Authors:  Bao-Le Zhang; Jie Liu; Yu Lei; Ye Xiong; Heng Li; Xiaoqian Lin; Rui-Qin Yao; Dian-Shuai Gao
Journal:  Mol Neurobiol       Date:  2015-08-01       Impact factor: 5.590

9.  A microfluidic platform to study the effects of GDNF on neuronal axon entrapment.

Authors:  Ze Zhong Wang; Matthew D Wood; Susan E Mackinnon; Shelly E Sakiyama-Elbert
Journal:  J Neurosci Methods       Date:  2018-08-03       Impact factor: 2.390

10.  Bioactive Nanofiber-Based Conduits in a Peripheral Nerve Gap Management-An Animal Model Study.

Authors:  Tomasz Dębski; Ewa Kijeńska-Gawrońska; Aleksandra Zołocińska; Katarzyna Siennicka; Anna Słysz; Wiktor Paskal; Paweł K Włodarski; Wojciech Święszkowski; Zygmunt Pojda
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.